Genetic and epigenetic alterations in colon cancer

被引:226
作者
Grady, WM [1 ]
Markowitz, SD
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA
[2] Case Western Reserve Univ, Howard Hughes Med Inst, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ Hosp, Cleveland, OH 44106 USA
关键词
mutation; DNA methylation; genomic instability;
D O I
10.1146/annurev.genom.3.022502.103043
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Colorectal cancer affected approximately 135,000 people in the United States in 2001, resulting in 57,000 deaths. Colorectal cancer develops as the result of the progressive accumulation of genetic and epigenetic alterations that lead to the transformation of normal colonic epithelium to colon adenocarcinoma. The loss of genomic stability is a key molecular and pathophysiologic step in this process and serves to create a permissive environment for the occurrence of alterations in tumor suppressor genes and oncogenes. Alterations in these genes, which include APC, CTNNB1, K-RAS, MADH4/SMAD4, and TGFBR2, appear to promote colon tumorigenesis by perturbing the function of signaling pathways, such as the TGF-beta signaling pathway, or by affecting genes that regulate genomic stability, such as the mutation mismatch repair genes.
引用
收藏
页码:101 / 128
页数:28
相关论文
共 201 条
[71]   The genetics of colorectal cancer [J].
Howe, JR ;
Guillem, JG .
SURGICAL CLINICS OF NORTH AMERICA, 1997, 77 (01) :175-+
[72]   TRANSFORMING GROWTH FACTOR-BETA-1 INHIBITION OF P34CDC2 PHOSPHORYLATION AND HISTONE-H1 KINASE-ACTIVITY IS ASSOCIATED WITH G1/S-PHASE GROWTH ARREST [J].
HOWE, PH ;
DRAETTA, G ;
LEOF, EB .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) :1185-1194
[73]   Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene [J].
Hua, XX ;
Liu, XD ;
Ansari, DO ;
Lodish, HF .
GENES & DEVELOPMENT, 1998, 12 (19) :3084-3095
[74]   APC mutations in colorectal tumors with mismatch repair deficiency [J].
Huang, J ;
Papadopoulos, N ;
McKinley, AJ ;
Farrington, SM ;
Curtis, LJ ;
Wyllie, AH ;
Zheng, S ;
Willson, JKV ;
Markowitz, SD ;
Morin, P ;
Kinzler, KW ;
Vogelstein, B ;
Dunlop, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) :9049-9054
[75]   E-CADHERIN AND APC COMPETE FOR THE INTERACTION WITH BETA-CATENIN AND THE CYTOSKELETON [J].
HULSKEN, J ;
BIRCHMEIER, W ;
BEHRENS, J .
JOURNAL OF CELL BIOLOGY, 1994, 127 (06) :2061-2069
[76]  
Iacopetta BJ, 1998, J PATHOL, V184, P390
[77]  
Ikeda M, 1998, CANCER RES, V58, P594
[78]   The TAK1-NLK-MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF [J].
Ishitani, T ;
Ninomiya-Tsuji, J ;
Nagai, S ;
Nishita, M ;
Meneghini, M ;
Barker, N ;
Waterman, M ;
Bowerman, B ;
Clevers, H ;
Shibuya, H ;
Matsumoto, K .
NATURE, 1999, 399 (6738) :798-802
[79]   GENETIC INSTABILITY ASSOCIATED WITH ADENOMA TO CARCINOMA PROGRESSION IN HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
JACOBY, RF ;
MARSHALL, DJ ;
KAILAS, S ;
SCHLACK, S ;
HARMS, B ;
LOVE, R .
GASTROENTEROLOGY, 1995, 109 (01) :73-82
[80]   ALLELIC LOSS OF CHROMOSOME 18Q AND PROGNOSIS IN COLORECTAL-CANCER [J].
JEN, J ;
KIM, HG ;
PIANTADOSI, S ;
LIU, ZF ;
LEVITT, RC ;
SISTONEN, P ;
KINZLER, KW ;
VOGELSTEIN, B ;
HAMILTON, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (04) :213-221